About WoundClot™ Trauma
WoundClot™ Trauma is an advanced hemostatic dressing, specifically engineered for the control of moderate to severe bleeding in traumatic injuries. Provides rapid, reliable hemorrhage control in emergency and field settings.
- Provides effective hemostasis without the need for manual compression
- Exhibits a high safety profile with no known contraindications, except in cases of hypersensitivity to the device’s constituent materials.
- Suitable for application to any external area of the body
- Available in multiple sizes and designed to conform effectively to diverse anatomical contours
- Demonstrates zero toxicity, with no harmful side effects or residual by-products
- Designed for ease of use, requiring minimal training for effective application
Available Sizes
| 10 cm x 10 cm ( 4” x 4” ) |
8 cm x 20 cm ( 3” x 8” ) |
8 cm x 100 cm ( 3” x 39” ) |
20 cm x 30 cm ( 8” x 10” ) |
|
|---|---|---|---|---|
| Product Number | 102111101 | 102182101 | 102181101 | 102123101 |
| Description | Peel Open Package | Peel Open Package | Peel Open Package | Peel Open Package |
| Pieces Per Box | 10 | 10 | 10 | 5 |
How It Works
When applied to a bleeding site, WoundClot™ quickly transforms from a dry, flexible gauze into a dense, durable, and expanding 3D gel matrix. This stable and adaptable structure supports fast, reliable hemostasis through multiple mechanisms of action.
Absorption
WoundClot™’s 3D gel matrix absorbs up to 2,500% of its weight in blood and remains actively absorbent for up to 24 hours.
Adhesion
WoundClot™’s flexible 3D gel matrix conforms to and adheres securely to the surrounding tissue within the wound site.
FAQ
WoundClot™ Trauma is composed of cellulose—a natural, plant-derived fibre—uniquely engineered into a Non-Oxidised, Non-Regenerated Cellulosic Structure (NONRCS). Unlike conventional cellulose-based hemostatic agents, which are produced using outdated oxidation processes that degrade the material’s integrity, WoundClot™ maintains the full functional capacity of cellulose. This advanced structure enhances its ability to absorb blood, adhere to wound surfaces, and support rapid and effective hemostasis.
WoundClot™Trauma is composed entirely of cellulose, a natural plant-based fibre. Unlike traditional hemostatic agents that rely on added active ingredients, such as kaolin, chitosan, collagen, silica, or thrombin, WoundClot™ is inherently hemostatic due to its patented manufacturing process. This unique process transforms the cellulose into a bioactive structure that promotes hemostasis without the need for any pharmacological additives.
WoundClot™Trauma employs a multi-modal mechanism of action that sets it apart from all other hemostatic agents currently available. Upon contact with blood, its patented Non-Oxidised, Non-Regenerated Cellulosic Structure (NONRCS) rapidly transforms into a cohesive, expanding gel that adheres securely to wound surfaces. This gel matrix promotes localized clot formation without the need for manual compression.
WoundClot™Trauma is exceptionally absorbent, capable of absorbing up to 3,000% of its weight in fluid, and remains actively absorbent for up to 24 hours. With a strong safety profile, it is suitable for use on all external anatomical sites and is designed for ease of use, requiring minimal training for effective application.
WoundClot™ Trauma features one of the fastest bioresorption profiles among surgical hemostatic agents. Its bioabsorbable structure is gradually broken down and safely resorbed by the body, minimising the risk of foreign body reactions and eliminating the need for removal.
WoundClot™ Trauma can be easily removed by lifting the stabilized clot from the wound site. Its atraumatic removal does not induce rebleeding and any residual gel can be gently irrigated and cleared without difficulty, supporting a clean wound environment and optimal healing conditions.
WoundClot™ Trauma has a shelf life of 5 years, offering long-term storage stability for hospitals, emergency services and military medical supplies.